Delivery Order SPE2DB20D2001-SPE2DB25FPNVR
- Not listed
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,350.81 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on July 14, 2025, with completion targeted for July 15, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,881.99 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $1,117.20 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg, a diabetes management medication. This competitively awarded, firm fixed-price contract was executed on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract carries no set-aside designation and represents a discrete order fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Januvia 100 mg tablets (90-count) with a ceiling value of $9,111.37. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The delivery order was...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract ceiling value of $50,372.45 and a firm fixed-price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPNVRDelivery Order
The Defense Logistics Agency (DLA) awarded a $14,019.04 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same city. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages its comprehensive DLA Troop Support Medical prime contract to supply pharmaceutical products and medical supplies to military and veteran healthcare systems. The Januvia supply supports the company's broader role in providing diabetes management medications and other therapeutic pharmaceuticals to Defense Health Agency customers and other federal healthcare programs. This delivery order exemplifies the routine pharmaceutical procurement activities conducted under AmerisourceBergen's global pharmaceutical support vehicle, which enables flexible fulfillment of medical supply needs across military healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.0k | 9/26/25 |